Why Genetic Testing May Be Our Best Shot at Progress in PD

A growing body of research suggests that genes may be our best shot at advancing the treatment and management of Parkinson's disease, prompting experts to call for broad-based genetic testing.

Related Keywords

Salt Lake City ,Utah ,United States ,New York ,Israel ,Roy Alcalay ,James Beck ,Sanofi Genzyme ,Kathleene Mckee ,Parkinson Foundation ,Movement Disorders Division ,A Research Driver ,Intermountain Health ,Neurological Institute Of New York ,Laboratory Of Biomarkers ,Presbyterian Medical Center ,Global Parkinson Genetics Program ,Medscape Medical ,Neurological Institute ,Columbia Presbyterian Medical ,Tel Aviv Sourasky Medical Center ,Global Parkinson ,Genetics Program ,Aligning Science Across Parkinson ,Parkinsons Disease ,Genetic Testing ,Genetics ,Neurodegenerative Disease ,Clinical Research ,Clinical Trials ,Linical Studies ,